Pyrotinib

pyrotinib · Jiangsu Hengrui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

106 regulatory and trial events tracked for Pyrotinib, covering 2015-03-04 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung Cancer [Phase 1, Phase 2]

See pricing